Eventide Asset Management - BELLICUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$1,604,000
-52.9%
130,000
-48.0%
0.11%
-52.3%
Q4 2016$3,405,000250,0000.22%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$3,070,0000.79%
X-Square Capital, LLC 109,832$321,0000.25%
KNOTT DAVID M 111,427$325,0000.15%
ARK Investment Management 1,033,491$3,018,0000.12%
Baker Brothers Advisors 2,677,818$7,819,0000.06%
HARVEY CAPITAL MANAGEMENT INC 31,200$91,0000.05%
DAFNA Capital Management LLC 30,000$88,0000.04%
WASATCH ADVISORS LP 953,368$2,784,0000.04%
FRANKLIN STREET ADVISORS INC /NC 51,415$150,0000.02%
FARALLON CAPITAL MANAGEMENT LLC 1,000,000$2,920,0000.02%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders